Skip to content
Global Access Atlas

Market access pathways by country

Explore how an innovative medicine moves from approval to patient access.

Selected market

United States

FDA approval is followed by separate public and commercial payer decisions; there is no single national formulary gate.

FDA
CMS / payers
Manufacturers / PBMs
CMS / plans
4 decision nodes15 cited sources

For education only — not regulatory, pricing or legal advice.

About the content and how to use it